Virginia Retirement Systems Et Al Regeneron Pharmaceuticals, Inc. Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 128,454 shares of REGN stock, worth $90.2 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

128,454

Previous 115,954 10.78%

Holding current value

$90.2 Million

Previous $83.3 Million 26.88%

% of portfolio

1.05%

Previous 0.8%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	BUY	$692.45 - $844.37 $8.66 Million - $10.6 Million	12,500 Added 10.78%	128,454 $106 Million
Q2 2023 Aug 22, 2023	BUY	$700.03 - $830.35 $7.91 Million - $9.38 Million	11,300 Added 10.8%	115,954 $83.3 Million
Q1 2023 Jul 11, 2023	BUY	$680.49 - $826.97 $20.1 Million - $24.4 Million	29,554 Added 39.35%	104,654 $86 Million
Q4 2022 May 17, 2023	BUY	$705.89 - $766.39 $5.29 Million - $5.75 Million	7,500 Added 11.09%	75,100 $54.2 Billion
Q3 2022 May 16, 2023	SELL	$573.97 - $724.32 $11.7 Million - $14.7 Million	-20,300 Reduced 23.09%	67,600 $46.6 Billion
Q1 2022 Apr 21, 2022	SELL	$595.12 - $698.43 $18.9 Million - $22.1 Million	-31,700 Reduced 26.51%	87,900 $61.4 Million
Q3 2021 Oct 21, 2021	SELL	$574.03 - $680.96 $4.31 Million - $5.11 Million	-7,500 Reduced 5.9%	119,600 $72.4 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $94,560 - $111,708	-200 Reduced 0.16%	127,100 $71 Million
Q1 2021 Apr 30, 2021	BUY	$446.73 - $548.2 $3.13 Million - $3.84 Million	7,000 Added 5.82%	127,300 $60.2 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $2.15 Million - $2.74 Million	4,500 Added 3.89%	120,300 $58.1 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $7.84 Million - $9.48 Million	14,400 Added 14.2%	115,800 $64.8 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $19.6 Million - $25.6 Million	39,800 Added 64.61%	101,400 $63.2 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $6.08 Million - $8.95 Million	18,100 Added 41.61%	61,600 $30.1 Million
Q3 2019 Oct 22, 2019	SELL	$273.46 - $318.39 $3.55 Million - $4.14 Million	-13,000 Reduced 23.01%	43,500 $12.1 Million
Q2 2019 Jul 26, 2019	SELL	$299.6 - $414.82 $11.5 Million - $15.9 Million	-38,300 Reduced 40.4%	56,500 $17.7 Million
Q1 2019 Apr 25, 2019	BUY	$372.08 - $439.57 $14.7 Million - $17.3 Million	39,400 Added 71.12%	94,800 $38.9 Million
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $1.51 Million - $1.81 Million	4,500 Added 8.84%	55,400 $20.7 Million
Q3 2018 Nov 02, 2018	BUY	$351.14 - $408.51 $5.09 Million - $5.92 Million	14,500 Added 39.84%	50,900 $20.6 Million
Q2 2018 Aug 03, 2018	BUY	$284.6 - $344.99 $10.4 Million - $12.6 Million	36,400 New	36,400 $12.6 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Regeneron Pharmaceuticals, Inc. Transaction History